| 000 | 01884 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517234639.0 | ||
| 264 | 0 | _c20190403 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1878-1519 | ||
| 024 | 7 |
_a10.1016/j.resp.2018.08.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRichard, Chloé | |
| 245 | 0 | 0 |
_aAlveolar liquid clearance in lung injury: Evaluation of the impairment of the β _h[electronic resource] |
| 260 |
_bRespiratory physiology & neurobiology _c01 2019 |
||
| 300 |
_a104-110 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAminophylline _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aBronchodilator Agents _xpharmacology |
| 650 | 0 | 4 |
_aCyclic AMP _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEpithelial Sodium Channels _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 |
_aImidazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aIodine Radioisotopes _xpharmacokinetics |
| 650 | 0 | 4 |
_aIodocyanopindolol _xpharmacokinetics |
| 650 | 0 | 4 |
_aLung Injury _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPropanolamines _xtherapeutic use |
| 650 | 0 | 4 |
_aProtein Binding _xdrug effects |
| 650 | 0 | 4 |
_aPulmonary Alveoli _xphysiopathology |
| 650 | 0 | 4 |
_aPulmonary Edema _xetiology |
| 650 | 0 | 4 | _aRNA, Messenger |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, beta-2 _xtherapeutic use |
| 650 | 0 | 4 |
_aReperfusion Injury _xcomplications |
| 700 | 1 | _aShabbir, Waheed | |
| 700 | 1 | _aFerraro, Pasquale | |
| 700 | 1 | _aMassé, Chantal | |
| 700 | 1 | _aBerthiaume, Yves | |
| 773 | 0 |
_tRespiratory physiology & neurobiology _gvol. 259 _gp. 104-110 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.resp.2018.08.006 _zAvailable from publisher's website |
| 999 |
_c28792895 _d28792895 |
||